Comment by sanxiyn

My understanding is that protein folding is not a bottleneck in drug design.

Yes, once you identified a target protein, its structure is useful to selectively target it. But the main bottleneck is identifying such targets. In other words, the main difficulty is to figure out what to hit, not how to hit it, and protein folding mostly helps with how at the moment.